Higher glutathione transferase GSTM1 0/0 genotype frequency in young thyroid carcinoma patients

Current Medical Research and Opinion

Volumn 19, Issue 2, 2003, Pages 103-106

  Canbay, Emel ^a   Dokmetas, Sebila ^a   Canbay, Ercan Ismet ^a   Sen, Metin ^a   Bardakci, Fevzi ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Alleles; Gene deletion; Gene frequency; Glutathione transferase; Thyroid carcinoma

Indexed keywords

BIOLOGICAL MARKER; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; HUMAN; MALE; NULL ALLELE; POLYMERASE CHAIN REACTION; SMOKING; THYROID CARCINOMA;

EID: 0038297510     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125001425     Document Type: Article

References (19)

1. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defense against oxidative stress. Free Radic Res 1999;31:273-300
2. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600
3. Daniel V. Glutathione S-transferases: gene structure and regulation of expression. Crit Rev Biochem Mol Biol 1993;28:173-207
4. Mannervik B, Danielson UH. Glutathione transferases-structure and catalytic activity. CRC Crit Rev Biochem 1988;23:283-337
5. Emahazion T, Jobs M, Howell WM, Siegfried M, Wyoni PI, Prince JA, Brookes AJ. Identification of 167 polymorphism in 88 genes from candidate neurodegeneration pathways. Gene 1999;238:315-24
6. Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994;15:1077-81
7. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993;14:1479-81
8. Oude Ophuis MB, van Lieshout EMM, Roelofs HMJ, Peters WHM, Manni JJ. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer 1998;82:936-43
9. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, Ookuma R, Bell DA. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996;17:1855-9
10. Brockmöller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996;56:3915-25
11. Shanley SM, Chenevix-Trench G, Palmer J, Hayward N. Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma. Carcinogenesis 1995;16:2003-4
12. Farid NR. Molecular pathogenesis of thyroid cancer: the significance of oncogenes, tumor suppressor genes, and genomic instability. Exp Clin Endocrinol Diabetes 1996;104, 1-12
13. Gonsky R, Knauf JA, Elisei R, Wang JW, Su S, Fagin JA. Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets. Nucleic Acids Res 1997;25:3823-31
14. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Liu G, Higashiyama T, Morita S, Kuma K, Amino N. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Cancer Res 1998;58:4913-17
15. Lupoli G, Cascone E, Vitale G, Arlotta F, Nuzzo V, Lupoli G Jr, Cassese B. Risk factors and prevention of thyroid carcinoma. Minerva Endocrinol 1996;21:93-100
16. Alves C, Silva F, Gusmao L, Seruca R, Soares P, Reis RM, Amorim A. Extended structural variation of a pentanucleotide repeat in the GSTP1 gene: characterization in a normal population and in thyroid and gastric tumours. Eur J Human Genet 2000;8:540-4
17. Lafuente A, Pujol F, Carretero P, Villa JP, Cuchi A. Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 1993;68:49-54
18. Jourenkova N, Reinikainen M, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. Larynx cancer risk in relation to glutathione Stransferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol Biomarkers Prevent 1998;7:19-23
19. Vineis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int J Cancer 1997;71:1-3